[Mood disorders in perimenopausal women: hormone replacement or antidepressant therapy?]
- PMID: 16223218
[Mood disorders in perimenopausal women: hormone replacement or antidepressant therapy?]
Abstract
Perimenopause (and not the entire postmenopausal period) is a period at risk for depression. Menopause is a psychosocial and physiologic reality whose neurobiological aspects are often under-estimated. Various disturbances, such as hot flushes and, at least in part, depressive disorders, are related to this neurobiological dimension. When the depression is minor, hormone replacement therapy may be an adequate treatment. Keeping in mind the complex interactions that may occur between endogenous and exogenous progestins at the neuronal level, we would recommend a physiologic replacement using transdermal estradiol and vaginal progesterone. When the depression is major, present data do not support the possibility of using hormone replacement therapy instead of antidepressants.
Similar articles
-
Depression and the menopause: why antidepressants are not enough?Menopause Int. 2009 Jun;15(2):76-81. doi: 10.1258/mi.2009.009021. Menopause Int. 2009. PMID: 19465674 Review.
-
Augmentation of antidepressants by estrogen.Psychopharmacol Bull. 1998;34(3):319-21. Psychopharmacol Bull. 1998. PMID: 9803763 Review.
-
Neurophysiologic changes during estrogen augmentation in perimenopausal depression.Maturitas. 2007 Jan 20;56(1):54-60. doi: 10.1016/j.maturitas.2006.05.010. Epub 2006 Jul 10. Maturitas. 2007. PMID: 16835012 Clinical Trial.
-
Prevalence of hormone replacement therapy and antidepressant use in peri- and postmenopausal women.J Gend Specif Med. 2001;4(1):60-3. J Gend Specif Med. 2001. PMID: 11324242
-
Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations.Menopause. 2018 Oct;25(10):1069-1085. doi: 10.1097/GME.0000000000001174. Menopause. 2018. PMID: 30179986
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical